Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Novartis and IBM Watson Health announce cancer research alliance

Novartis and IBM Watson Health announce cancer research alliance

7th June 2017

Novartis has announced a new collaboration with IBM Watson Health that aims to find ways of improving standards of care for breast cancer patients.

The companies will work together on the development of a cognitive solution that uses real-world data and advanced analytical techniques to provide better insights on the expected outcomes of breast cancer treatment options.

Novartis will contribute its expertise in breast cancer, with IBM Watson Health leveraging its skills in data analytics and machine learning, to determine combinations and sequences that may lead to the best patient outcomes.

Watson is the first commercially available cognitive computing technology able to analyse high volumes of data, understand complex questions posed in natural language, and propose evidence-based answers, while learning from these interactions over time.

Bruno Strigini, chief executive officer of Novartis Oncology, said: "We will use real-world breast cancer data and cognitive computing to identify solutions that may help physicians better understand which therapy may be best for which patients or advise clinical practice guidelines."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801836616-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.